진통펩타이드 K7DA의 혈액-뇌 관문을 통한 vector-mediated delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강영숙 | - |
dc.date.accessioned | 2022-04-25T00:40:08Z | - |
dc.date.available | 2022-04-25T00:40:08Z | - |
dc.date.issued | 1997-03 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/151283 | - |
dc.description.abstract | [Lys^7]dermorphin, abbreviated K7DA, which has structural features similar to a metabolically stable μ-opioid peptide agonist [D-Arg², Lys⁴]dermorphin analogue (DALDA), but is intrinsically more potent with respect to binding to the μ-opioid peptide receptor. The present studies report on attempts to enhance brain uptake of systemically administered K7DA by conjugation to a complex of streptavidin (SA) and the OX26 murine monoclonal antibody to the rat transferrin receptor, which undergoes receptor-mediated transcytosis through the blood-brain barrier (BBB). SA-OX26 conjugate mediates BBB transport of biotinylated therapeutics. The K7DA is monobiotinylated at the ε-amino group of the Lys^7 residue with cleavable linker using NHS-SS-biotin. The brain uptake of ^(125)I-labeled biotinylated K7DA (^(125)I-bio-SS-K7DA) was very small and rapidly metabolized after intravenous injection. The brain uptake, expressed as percent of injected dose delivered per gram of brain, of the ^(125)I-bio-SS-K7DA bound to the SA-OX26 conjugate (^(125)I-bio-SS-K7DA/SA-OX26) was 0.14±0.01, a level that is 2-fold greater than the brain uptake of morphine. The cleavability of the disulfide linker in vivo in rat plasma and brain was assessed with gel filtration HPLC and intravenous injection of labeled opioid chimeric peptides. The disulfide linker is stable in plasma in vivo but is cleaved in rat brain in vivo. In conclusion, these studies show that delivery of these potential opioid peptides to the brain may be improved by coupling them to vector-mediated BBB drug delivery system. | - |
dc.format.extent | 6 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 한국응용약물학회 | - |
dc.title | 진통펩타이드 K7DA의 혈액-뇌 관문을 통한 vector-mediated delivery | - |
dc.title.alternative | Vector-Mediated Delivery of 125 I-labeled Opioid Peptide , [Lys7]dermorphin (K7DA) , through the Blood-Brain Barrier | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | 응용약물학회지 (Biomolecules & Therapeutics, v.5, no.1, pp 53 - 58 | - |
dc.citation.title | 응용약물학회지 (Biomolecules & Therapeutics | - |
dc.citation.volume | 5 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 53 | - |
dc.citation.endPage | 58 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.url | https://kiss.kstudy.com/thesis/thesis-view.asp?key=424828 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.